Bristol-Myers shares fall after it withdraws FDA application for combo lung cancer treatment
January 24, 2019 at 08:09 AM EST
The New York-based pharmaceutical giant said it pulled its applications for a combination of its immunotherapy drugs Opdivo and Yervoy after recent discussions with the FDA.